Ligand validation:2Y46

MIV: MYCINAMICIN IV

MIV is a Ligand Of Interest in 2Y46 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y46_MIV_B_460	75%	34%	0.107	0.94	1.01	1.56	2	12	1	0	100%	1
2Y46_MIV_C_460	73%	33%	0.104	0.93	1.06	1.59	3	12	0	0	100%	1
2Y46_MIV_A_460	71%	35%	0.117	0.938	1.11	1.45	2	10	1	0	100%	1
3ZSN_MIV_B_460	51%	33%	0.129	0.881	1.18	1.47	2	12	3	0	100%	1
2Y98_MIV_A_460	46%	32%	0.151	0.886	1.37	1.35	3	12	0	0	100%	0.9469
4X7V_MIV_B_302	55%	10%	0.135	0.903	2.9	1.49	10	14	1	0	100%	1
7A18_MIV_X_2901	25%	44%	0.259	0.894	0.72	1.42	2	7	6	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.